CCL2 and cancer: A number of pathways involved in cancer and cell survival were upregulated in Mmtv-Ccl2 mice compared to wildtype controls including proteoglycans in cancer (p = 1.39 × 10−8), cell cycle (p = 7.36 × 10−5), pathways in cancer (p = 4.4 × 10−4), Ras signalling (p = 0.0162) and PI3K-Akt signalling (p = 4.23 × 10−4).